Vorinostat Recruiting Phase 1 Trials for Infection, Human Immunodeficiency Virus I Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT03212989Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on ART
NCT03803605Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons